US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProQR Therapeutics NV

1.37

-0.1300-8.67%

Post-market: 1.470.1038+7.58%19:35 EDT

Volume:566.46K

Turnover:790.31K

Market Cap:144.32M

PE:-2.91

High:1.51

Open:1.51

Low:1.35

Close:1.50

52wk High:3.10

52wk Low:1.07

Shares:105.35M

Float Shares:67.53M

Volume Ratio:2.64

T/O Rate:0.84%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4702

EPS(LYR):-0.4702

ROE:-61.17%

ROA:-19.35%

PB:2.53

PE(LYR):-2.91

Loading ...

Overview Company News Filings

ProQR Therapeutics to host virtual investor and analyst event; pipeline spotlight to include AX-0810 indication update

ProQR Therapeutics’ Chief Scientific Officer Gerardus Johannes Platenburg files initial beneficial ownership statement

ProQR Therapeutics NV Director Domenico Valerio Files Initial Beneficial Ownership Statement

ProQR Therapeutics NV CFO Dennis Hom files initial beneficial ownership statement

ProQR Therapeutics director Alison Frances Lawton files Form 3 initial beneficial ownership statement

ProQR Therapeutics NV Director Theresa Heggie files initial beneficial ownership statement

ProQR Therapeutics NV Director Bart Filius Files Initial Beneficial Ownership Statement

ProQR Therapeutics NV CEO and Director Daniel Anton de Boer files initial beneficial ownership statement

ProQR Therapeutics NV Director Begona Carreno-Gomez Files Initial Beneficial Ownership Statement

ProQR Therapeutics NV files Form 3 initial beneficial ownership statement for Director Shannon James Samuel

ProQR Therapeutics Q4 Net Loss Of €8.9 Million Reinforces Profitability Concerns

Simply Wall St.

ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty

ProQR Therapeutics NV reports results for the quarter ended December 31 - Earnings Summary

ProQR FY 2025 net loss rises 52% to EUR 42.2 million as cash falls 38% to EUR 92.4 million

ProQR Announces Year End 2025 Operating and Financial Results

THOMSON REUTERS

ProQR Therapeutics NV expected to post a loss of 10 cents a share - Earnings Preview

ProQR Therapeutics to Present at Citizens Life Sciences Conference

ProQR Therapeutics kündigt Wechsel im Vorstand an

BRIEF-Proqr Announces Encouraging Ax-0810 Phase 1

ProQR Reports Positive Initial Safety Data from AX-0810 Phase 1 Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PRQR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRQR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRQR\",,,,,undefined,":{"symbol":"PRQR","market":"US","secType":"STK","nameCN":"ProQR Therapeutics NV","latestPrice":1.37,"timestamp":1774641600000,"preClose":1.5,"halted":0,"volume":566464,"hourTrading":{"tag":"盘后","latestPrice":1.4738,"preClose":1.37,"latestTime":"19:35 EDT","volume":443,"amount":643.2074,"timestamp":1774654520873,"change":0.1038,"changeRate":0.075766,"amplitude":0.075766},"delay":0,"changeRate":-0.0866666666666666,"floatShares":67530657,"shares":105345192,"eps":-0.470209,"marketStatus":"Market Closed","change":-0.13,"latestTime":"03-27 16:00:00 EDT","open":1.51,"high":1.51,"low":1.35,"amount":790310.5766208001,"amplitude":0.106667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.470209,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1411012800000,"exchange":"NASDAQ","adjPreClose":1.5,"postHourTrading":{"tag":"盘后","latestPrice":1.4738,"preClose":1.37,"latestTime":"19:35 EDT","volume":443,"amount":643.2074,"timestamp":1774654520873,"change":0.1038,"changeRate":0.075766,"amplitude":0.075766},"volumeRatio":2.638835,"impliedVol":0.0393,"impliedVolPercentile":0.1116},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRQR\",,,,,undefined,":{"symbol":"PRQR","floatShares":67530657,"roa":"-19.35%","roe":"-61.17%","lyrEps":-0.470209,"volumeRatio":2.638835,"shares":105345192,"dividePrice":0,"high":1.51,"amplitude":0.106667,"preClose":1.5,"low":1.35,"week52Low":1.07,"pbRate":"2.53","psRate":"7.65","week52High":3.1,"institutionHeld":0,"latestPrice":1.37,"eps":-0.470209,"divideRate":0,"volume":566464,"delay":0,"ttmEps":-0.470209,"open":1.51,"prevYearClose":2.02,"prevWeekClose":1.54,"prevMonthClose":1.59,"prevQuarterClose":2.02,"fiveDayClose":1.54,"twentyDayClose":1.59,"sixtyDayClose":2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRQR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-12","symbol":"PRQR","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2025-11-06","symbol":"PRQR","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-07","symbol":"PRQR","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-05-08","symbol":"PRQR","fiscalQuarterEnding":"2025/03","expectedEps":-0.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-03-13","symbol":"PRQR","fiscalQuarterEnding":"2024/12","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRQR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRQR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1745899200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRQR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRQR","date":"2026-03-27","current":-2.913598,"percent":0.625612,"low":-16.412594,"twenty":-7.429906,"median":-4.617864,"eighty":-1.94931,"high":-0.596848,"avg":-4.868092,"sd":3.226775,"marketCap":158041596},"quantilePoints":[{"date":"2021-04-01","current":-7.645601,"twenty":-7.887455,"median":-5.43111,"eighty":-3.12218,"marketCap":418893304},{"date":"2021-04-09","current":-7.445043,"twenty":-7.895523,"median":-5.424027,"eighty":-3.121338,"marketCap":411976736},{"date":"2021-04-16","current":-7.113097,"twenty":-7.871083,"median":-5.424027,"eighty":-3.121338,"marketCap":396767322},{"date":"2021-04-23","current":-7.288239,"twenty":-7.854969,"median":-5.424027,"eighty":-3.121338,"marketCap":409331620},{"date":"2021-04-30","current":-7.342994,"twenty":-7.854969,"median":-5.424027,"eighty":-3.121338,"marketCap":411315457},{"date":"2021-05-07","current":-7.861736,"twenty":-7.856897,"median":-5.424027,"eighty":-3.121338,"marketCap":411976736},{"date":"2021-05-14","current":-8.099694,"twenty":-7.896763,"median":-5.424027,"eighty":-3.121338,"marketCap":423879755},{"date":"2021-05-21","current":-8.141773,"twenty":-7.984904,"median":-5.463377,"eighty":-3.121338,"marketCap":427847428},{"date":"2021-05-28","current":-7.852343,"twenty":-7.984904,"median":-5.470528,"eighty":-3.121338,"marketCap":412638014},{"date":"2021-06-04","current":-8.054822,"twenty":-8.00088,"median":-5.470528,"eighty":-3.121338,"marketCap":422557197},{"date":"2021-06-11","current":-8.570985,"twenty":-8.048804,"median":-5.470528,"eighty":-3.121338,"marketCap":447024516},{"date":"2021-06-18","current":-9.818903,"twenty":-8.079257,"median":-5.470528,"eighty":-3.121338,"marketCap":501910662},{"date":"2021-06-25","current":-9.15602,"twenty":-8.120797,"median":-5.470528,"eighty":-3.121338,"marketCap":471491834},{"date":"2021-07-02","current":-8.430733,"twenty":-8.15395,"median":-5.470528,"eighty":-3.121338,"marketCap":430492544},{"date":"2021-07-09","current":-8.234772,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":421234640},{"date":"2021-07-16","current":-7.273715,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":370316167},{"date":"2021-07-23","current":-7.157782,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":363042099},{"date":"2021-07-30","current":-6.761847,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":345848849},{"date":"2021-08-06","current":-6.518909,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":419852760},{"date":"2021-08-13","current":-6.529347,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":421864833},{"date":"2021-08-20","current":-5.798685,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":370892294},{"date":"2021-08-27","current":-6.794467,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":438632116},{"date":"2021-09-03","current":-7.122997,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":463447695},{"date":"2021-09-10","current":-8.491936,"twenty":-8.167753,"median":-5.470528,"eighty":-3.121338,"marketCap":549966874},{"date":"2021-09-17","current":-8.83899,"twenty":-8.212316,"median":-5.470528,"eighty":-3.121338,"marketCap":568075539},{"date":"2021-09-24","current":-8.149406,"twenty":-8.167753,"median":-5.470528,"eighty":-3.121338,"marketCap":522468530},{"date":"2021-10-01","current":-8.654141,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":549296182},{"date":"2021-10-08","current":-8.203447,"twenty":-8.149326,"median":-5.470528,"eighty":-3.121338,"marketCap":519785765},{"date":"2021-10-15","current":-8.320782,"twenty":-8.15238,"median":-5.470528,"eighty":-3.121338,"marketCap":528504752},{"date":"2021-10-22","current":-7.824676,"twenty":-8.15238,"median":-5.470528,"eighty":-3.121338,"marketCap":498323643},{"date":"2021-10-29","current":-8.178311,"twenty":-8.162041,"median":-5.470528,"eighty":-3.121338,"marketCap":517773691},{"date":"2021-11-05","current":-9.146793,"twenty":-8.201922,"median":-5.481201,"eighty":-3.121338,"marketCap":598409942},{"date":"2021-11-12","current":-8.562754,"twenty":-8.24238,"median":-5.481201,"eighty":-3.121338,"marketCap":555005653},{"date":"2021-11-19","current":-8.625518,"twenty":-8.299175,"median":-5.481201,"eighty":-3.121338,"marketCap":552871016},{"date":"2021-11-26","current":-7.985271,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":511601365},{"date":"2021-12-03","current":-7.348261,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":469620168},{"date":"2021-12-10","current":-7.520518,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":481716445},{"date":"2021-12-17","current":-8.281698,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":528678462},{"date":"2021-12-23","current":-9.106985,"twenty":-8.345569,"median":-5.481201,"eighty":-3.121338,"marketCap":583467482},{"date":"2021-12-31","current":-8.851677,"twenty":-8.443858,"median":-5.481201,"eighty":-3.121338,"marketCap":569948113},{"date":"2022-01-07","current":-7.790788,"twenty":-8.489153,"median":-5.484397,"eighty":-3.12218,"marketCap":500216634},{"date":"2022-01-14","current":-7.438045,"twenty":-8.489153,"median":-5.484397,"eighty":-3.12218,"marketCap":481004899},{"date":"2022-01-21","current":-5.618039,"twenty":-8.489153,"median":-5.484397,"eighty":-3.12218,"marketCap":360753674},{"date":"2022-01-28","current":-5.854891,"twenty":-8.489153,"median":-5.502802,"eighty":-3.12218,"marketCap":370003769},{"date":"2022-02-04","current":-5.952741,"twenty":-8.489153,"median":-5.546321,"eighty":-3.12218,"marketCap":385657774},{"date":"2022-02-11","current":-1.531692,"twenty":-8.489153,"median":-5.589552,"eighty":-3.115687,"marketCap":98904853},{"date":"2022-02-18","current":-1.352949,"twenty":-8.489153,"median":-5.589552,"eighty":-2.993371,"marketCap":86808576},{"date":"2022-02-25","current":-1.088498,"twenty":-8.489153,"median":-5.589552,"eighty":-2.943204,"marketCap":75568253},{"date":"2022-03-04","current":-0.955778,"twenty":-8.489153,"median":-5.589552,"eighty":-2.917879,"marketCap":64282918},{"date":"2022-03-11","current":-1.02947,"twenty":-8.489153,"median":-5.50609,"eighty":-2.883893,"marketCap":69451502},{"date":"2022-03-18","current":-1.10861,"twenty":-8.489153,"median":-5.45436,"eighty":-2.853691,"marketCap":75568253},{"date":"2022-03-25","current":-0.942466,"twenty":-8.489153,"median":-5.343984,"eighty":-2.827898,"marketCap":63812399},{"date":"2022-04-01","current":-0.943355,"twenty":-8.489153,"median":-5.248209,"eighty":-2.809042,"marketCap":64161724},{"date":"2022-04-08","current":-0.989325,"twenty":-8.489153,"median":-5.169906,"eighty":-2.79609,"marketCap":66307577},{"date":"2022-04-14","current":-0.842377,"twenty":-8.489153,"median":-5.133326,"eighty":-2.78819,"marketCap":56098734},{"date":"2022-04-22","current":-0.80292,"twenty":-8.489153,"median":-5.098136,"eighty":-2.764386,"marketCap":53332651},{"date":"2022-04-29","current":-0.760779,"twenty":-8.489153,"median":-4.981596,"eighty":-2.733396,"marketCap":49404527},{"date":"2022-05-06","current":-0.678789,"twenty":-8.489153,"median":-4.91895,"eighty":-2.708705,"marketCap":45633244},{"date":"2022-05-13","current":-0.669176,"twenty":-8.489153,"median":-4.891957,"eighty":-2.696666,"marketCap":44200299},{"date":"2022-05-20","current":-0.717873,"twenty":-8.489153,"median":-4.883109,"eighty":-2.692655,"marketCap":48057131},{"date":"2022-05-27","current":-0.712869,"twenty":-8.489153,"median":-4.883109,"eighty":-2.689262,"marketCap":48463489},{"date":"2022-06-03","current":-0.822834,"twenty":-8.489153,"median":-4.883109,"eighty":-2.685958,"marketCap":55963281},{"date":"2022-06-10","current":-0.815564,"twenty":-8.489153,"median":-4.883109,"eighty":-2.677709,"marketCap":54459045},{"date":"2022-06-17","current":-0.787129,"twenty":-8.489153,"median":-4.883109,"eighty":-2.658676,"marketCap":52263289},{"date":"2022-06-24","current":-0.724232,"twenty":-8.489849,"median":-4.884777,"eighty":-2.618569,"marketCap":48477747},{"date":"2022-07-01","current":-0.8522,"twenty":-8.489849,"median":-4.884777,"eighty":-2.573268,"marketCap":56248445},{"date":"2022-07-08","current":-0.916161,"twenty":-8.489849,"median":-4.884777,"eighty":-2.514439,"marketCap":59171368},{"date":"2022-07-15","current":-0.890686,"twenty":-8.489849,"median":-4.884777,"eighty":-2.465673,"marketCap":57032644},{"date":"2022-07-22","current":-0.873686,"twenty":-8.489849,"median":-4.884777,"eighty":-2.409376,"marketCap":56676189},{"date":"2022-07-29","current":-0.922573,"twenty":-8.489849,"median":-4.884777,"eighty":-2.388231,"marketCap":59713178},{"date":"2022-08-05","current":-0.945118,"twenty":-8.489849,"median":-4.884777,"eighty":-2.361001,"marketCap":60086878},{"date":"2022-08-12","current":-0.956093,"twenty":-8.489849,"median":-4.884777,"eighty":-2.274685,"marketCap":61364259},{"date":"2022-08-19","current":-0.927788,"twenty":-8.489849,"median":-4.884777,"eighty":-2.219195,"marketCap":58309962},{"date":"2022-08-26","current":-0.90335,"twenty":-8.489849,"median":-4.884777,"eighty":-2.192301,"marketCap":56518773},{"date":"2022-09-02","current":-0.875124,"twenty":-8.489849,"median":-4.884777,"eighty":-2.165067,"marketCap":54955943},{"date":"2022-09-09","current":-0.892134,"twenty":-8.489849,"median":-4.884777,"eighty":-2.156993,"marketCap":56069192},{"date":"2022-09-16","current":-0.853137,"twenty":-8.489849,"median":-4.884777,"eighty":-2.139713,"marketCap":53521566},{"date":"2022-09-23","current":-0.891228,"twenty":-8.489849,"median":-4.884777,"eighty":-2.126751,"marketCap":54242323},{"date":"2022-09-30","current":-0.864972,"twenty":-8.489849,"median":-4.884777,"eighty":-2.122544,"marketCap":53093393},{"date":"2022-10-07","current":-0.962058,"twenty":-8.489849,"median":-4.884777,"eighty":-2.108014,"marketCap":58873722},{"date":"2022-10-14","current":-1.041103,"twenty":-8.489849,"median":-4.884777,"eighty":-2.088188,"marketCap":63512258},{"date":"2022-10-21","current":-1.055547,"twenty":-8.489849,"median":-4.884777,"eighty":-2.067935,"marketCap":64803912},{"date":"2022-10-28","current":-1.066265,"twenty":-8.489849,"median":-4.884777,"eighty":-2.044872,"marketCap":66366741},{"date":"2022-11-04","current":-1.063227,"twenty":-8.489849,"median":-4.884777,"eighty":-2.010069,"marketCap":65974250},{"date":"2022-11-11","current":-0.873744,"twenty":-8.489849,"median":-4.884777,"eighty":-2.005818,"marketCap":64926186},{"date":"2022-11-18","current":-1.20726,"twenty":-8.489849,"median":-4.884777,"eighty":-1.986496,"marketCap":90006595},{"date":"2022-11-25","current":-1.279522,"twenty":-8.489849,"median":-4.884777,"eighty":-1.97413,"marketCap":95721300},{"date":"2022-12-02","current":-1.278347,"twenty":-8.489849,"median":-4.884777,"eighty":-1.958524,"marketCap":96435638},{"date":"2022-12-09","current":-1.403815,"twenty":-8.489849,"median":-4.884777,"eighty":-1.944956,"marketCap":106436370},{"date":"2022-12-16","current":-1.460783,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":111436737},{"date":"2022-12-23","current":-2.533365,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":193587831},{"date":"2022-12-30","current":-3.43753,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":264308108},{"date":"2023-01-06","current":-3.339793,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":255021607},{"date":"2023-01-13","current":-3.147859,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":245020760},{"date":"2023-01-20","current":-2.574673,"twenty":-8.489849,"median":-4.884777,"eighty":-1.953213,"marketCap":200731293},{"date":"2023-01-27","current":-2.643382,"twenty":-8.489849,"median":-4.884777,"eighty":-1.983247,"marketCap":206446063},{"date":"2023-02-03","current":-2.882133,"twenty":-8.489849,"median":-4.884777,"eighty":-2.005818,"marketCap":225019065},{"date":"2023-02-10","current":-2.696295,"twenty":-8.489849,"median":-4.884777,"eighty":-2.059922,"marketCap":207160409},{"date":"2023-02-17","current":-2.877245,"twenty":-8.489849,"median":-4.884777,"eighty":-2.097942,"marketCap":220732988},{"date":"2023-02-24","current":-2.738533,"twenty":-8.489849,"median":-4.884777,"eighty":-2.109951,"marketCap":207874755},{"date":"2023-03-03","current":-2.782022,"twenty":-8.489849,"median":-4.884777,"eighty":-2.130285,"marketCap":212160833},{"date":"2023-03-10","current":-2.662513,"twenty":-8.489849,"median":-4.884777,"eighty":-2.380808,"marketCap":204303024},{"date":"2023-03-17","current":-3.027197,"twenty":-8.489849,"median":-4.884777,"eighty":-2.495321,"marketCap":232162528},{"date":"2023-03-24","current":-3.156679,"twenty":-8.489849,"median":-4.884777,"eighty":-2.541503,"marketCap":244306414},{"date":"2023-03-31","current":-2.150852,"twenty":-8.489153,"median":-4.883109,"eighty":-2.570165,"marketCap":152155749},{"date":"2023-04-06","current":-2.230286,"twenty":-8.489153,"median":-4.883109,"eighty":-2.570165,"marketCap":158584865},{"date":"2023-04-14","current":-2.549337,"twenty":-8.489849,"median":-4.884777,"eighty":-2.582741,"marketCap":183454769},{"date":"2023-04-21","current":-2.512198,"twenty":-8.489849,"median":-4.884777,"eighty":-2.590326,"marketCap":179413915},{"date":"2023-04-28","current":-2.455027,"twenty":-8.489849,"median":-4.884777,"eighty":-2.590802,"marketCap":176181232},{"date":"2023-05-05","current":-2.413965,"twenty":-8.489849,"median":-4.884777,"eighty":-2.588833,"marketCap":172948549},{"date":"2023-05-12","current":-2.284785,"twenty":-8.489849,"median":-4.884777,"eighty":-2.55209,"marketCap":162442328},{"date":"2023-05-19","current":-2.17895,"twenty":-8.489849,"median":-4.884777,"eighty":-2.532081,"marketCap":140621717},{"date":"2023-05-26","current":-2.099623,"twenty":-8.490544,"median":-4.885901,"eighty":-2.516561,"marketCap":134964521},{"date":"2023-06-02","current":-2.326845,"twenty":-8.490544,"median":-4.885901,"eighty":-2.490457,"marketCap":149730998},{"date":"2023-06-09","current":-2.199538,"twenty":-8.490544,"median":-4.885901,"eighty":-2.461763,"marketCap":142042109},{"date":"2023-06-16","current":-2.101451,"twenty":-8.490544,"median":-4.885901,"eighty":-2.407048,"marketCap":137590647},{"date":"2023-06-23","current":-2.106885,"twenty":-8.49124,"median":-4.887025,"eighty":-2.378088,"marketCap":138400004},{"date":"2023-06-30","current":-2.009341,"twenty":-8.491936,"median":-4.891957,"eighty":-2.326845,"marketCap":131115793},{"date":"2023-07-07","current":-2.138252,"twenty":-8.491936,"median":-4.891957,"eighty":-2.252526,"marketCap":139209361},{"date":"2023-07-14","current":-2.026818,"twenty":-8.491936,"median":-4.891957,"eighty":-2.200147,"marketCap":135971934},{"date":"2023-07-21","current":-2.023323,"twenty":-8.491936,"median":-4.891957,"eighty":-2.180738,"marketCap":135162577},{"date":"2023-07-28","current":-1.855368,"twenty":-8.491936,"median":-4.891957,"eighty":-2.158582,"marketCap":122212869},{"date":"2023-08-04","current":-1.949306,"twenty":-8.491936,"median":-4.891957,"eighty":-2.139154,"marketCap":115743931},{"date":"2023-08-11","current":-2.073061,"twenty":-8.491936,"median":-4.879307,"eighty":-2.10324,"marketCap":123837912},{"date":"2023-08-18","current":-2.085602,"twenty":-8.491936,"median":-4.805763,"eighty":-2.099323,"marketCap":123028514},{"date":"2023-08-25","current":-2.246265,"twenty":-8.491936,"median":-4.737622,"eighty":-2.099323,"marketCap":131931893},{"date":"2023-09-01","current":-2.208699,"twenty":-8.491936,"median":-4.665409,"eighty":-2.099323,"marketCap":129908398},{"date":"2023-09-08","current":-2.189826,"twenty":-8.450172,"median":-4.630519,"eighty":-2.099323,"marketCap":127075504},{"date":"2023-09-15","current":-2.252827,"twenty":-8.353734,"median":-4.605695,"eighty":-2.099323,"marketCap":130313097},{"date":"2023-09-22","current":-2.071584,"twenty":-8.299672,"median":-4.527985,"eighty":-2.096017,"marketCap":119790921},{"date":"2023-09-29","current":-1.878698,"twenty":-8.262873,"median":-4.476713,"eighty":-2.085602,"marketCap":107649949},{"date":"2023-10-06","current":-1.842919,"twenty":-8.211528,"median":-4.440923,"eighty":-2.063039,"marketCap":105221755},{"date":"2023-10-13","current":-1.71172,"twenty":-8.181611,"median":-4.404761,"eighty":-2.046551,"marketCap":97937172},{"date":"2023-10-20","current":-1.905135,"twenty":-8.156841,"median":-4.396533,"eighty":-2.028059,"marketCap":109268746},{"date":"2023-10-27","current":-1.686623,"twenty":-8.141951,"median":-4.388402,"eighty":-2.023484,"marketCap":96318376},{"date":"2023-11-03","current":-1.659065,"twenty":-8.126694,"median":-4.36878,"eighty":-2.008991,"marketCap":95508978},{"date":"2023-11-10","current":-2.875672,"twenty":-8.087318,"median":-4.340044,"eighty":-2.004739,"marketCap":112808915},{"date":"2023-11-17","current":-2.897141,"twenty":-8.054289,"median":-4.31625,"eighty":-2.004739,"marketCap":115243640},{"date":"2023-11-24","current":-3.007747,"twenty":-8.027496,"median":-4.301977,"eighty":-2.004739,"marketCap":120113089},{"date":"2023-12-01","current":-3.149662,"twenty":-8.001658,"median":-4.27966,"eighty":-2.004739,"marketCap":125794114},{"date":"2023-12-08","current":-4.190572,"twenty":-7.975228,"median":-4.241633,"eighty":-2.006078,"marketCap":165561285},{"date":"2023-12-15","current":-4.111906,"twenty":-7.949693,"median":-4.22793,"eighty":-2.006078,"marketCap":165561285},{"date":"2023-12-22","current":-4.052328,"twenty":-7.905172,"median":-4.213672,"eighty":-2.003399,"marketCap":163126560},{"date":"2023-12-29","current":-3.941559,"twenty":-7.888349,"median":-4.21066,"eighty":-1.996445,"marketCap":159880261},{"date":"2024-01-05","current":-4.044578,"twenty":-7.867452,"median":-4.206213,"eighty":-1.993638,"marketCap":162314986},{"date":"2024-01-12","current":-4.06881,"twenty":-7.852764,"median":-4.183098,"eighty":-1.993638,"marketCap":163126560},{"date":"2024-01-19","current":-4.324369,"twenty":-7.792996,"median":-4.182503,"eighty":-1.990831,"marketCap":172053885},{"date":"2024-01-26","current":-4.273828,"twenty":-7.778543,"median":-4.179683,"eighty":-1.993638,"marketCap":169619160},{"date":"2024-02-02","current":-4.433092,"twenty":-7.726078,"median":-4.179683,"eighty":-1.993638,"marketCap":176111759},{"date":"2024-02-09","current":-4.323598,"twenty":-7.67285,"median":-4.179683,"eighty":-1.993638,"marketCap":170430735},{"date":"2024-02-16","current":-4.01693,"twenty":-7.621102,"median":-4.170988,"eighty":-1.993638,"marketCap":158257111},{"date":"2024-02-23","current":-4.159233,"twenty":-7.593706,"median":-4.141829,"eighty":-1.993638,"marketCap":164749710},{"date":"2024-03-01","current":-4.131179,"twenty":-7.574049,"median":-4.132942,"eighty":-1.996445,"marketCap":163532348},{"date":"2024-03-08","current":-3.974545,"twenty":-7.531723,"median":-4.125469,"eighty":-1.996445,"marketCap":159068686},{"date":"2024-03-15","current":-6.162546,"twenty":-7.506446,"median":-4.111906,"eighty":-1.996445,"marketCap":188742653},{"date":"2024-03-22","current":-6.39449,"twenty":-7.488802,"median":-4.111906,"eighty":-1.996445,"marketCap":195251020},{"date":"2024-03-28","current":-6.374943,"twenty":-7.473277,"median":-4.111906,"eighty":-1.996445,"marketCap":193623928},{"date":"2024-04-05","current":-5.806436,"twenty":-7.442244,"median":-4.111906,"eighty":-1.993638,"marketCap":177353010},{"date":"2024-04-12","current":-6.213229,"twenty":-7.380266,"median":-4.111906,"eighty":-1.993638,"marketCap":187115561},{"date":"2024-04-19","current":-5.046675,"twenty":-7.352793,"median":-4.111906,"eighty":-1.993638,"marketCap":151319541},{"date":"2024-04-26","current":-5.293618,"twenty":-7.339896,"median":-4.111906,"eighty":-1.996445,"marketCap":159455000},{"date":"2024-05-03","current":-5.381552,"twenty":-7.333212,"median":-4.111906,"eighty":-1.996445,"marketCap":161895638},{"date":"2024-05-10","current":-5.370404,"twenty":-7.289181,"median":-4.111906,"eighty":-1.996445,"marketCap":162709184},{"date":"2024-05-17","current":-5.110593,"twenty":-7.251533,"median":-4.111906,"eighty":-1.996445,"marketCap":156200816},{"date":"2024-05-24","current":-5.312032,"twenty":-7.215454,"median":-4.111906,"eighty":-1.996445,"marketCap":154341593},{"date":"2024-05-31","current":-5.133933,"twenty":-7.208104,"median":-4.111906,"eighty":-1.996445,"marketCap":149441860},{"date":"2024-06-07","current":-5.563428,"twenty":-7.183119,"median":-4.111906,"eighty":-1.996445,"marketCap":162507815},{"date":"2024-06-14","current":-5.058744,"twenty":-7.155503,"median":-4.111906,"eighty":-1.993638,"marketCap":146175372},{"date":"2024-06-21","current":-4.854503,"twenty":-7.127873,"median":-4.111906,"eighty":-1.990831,"marketCap":139642394},{"date":"2024-06-28","current":-4.688687,"twenty":-7.103668,"median":-4.107562,"eighty":-1.987953,"marketCap":134742661},{"date":"2024-07-05","current":-4.61487,"twenty":-7.077921,"median":-4.107562,"eighty":-1.987953,"marketCap":133926039},{"date":"2024-07-12","current":-4.841286,"twenty":-7.047459,"median":-4.107562,"eighty":-1.987953,"marketCap":141275638},{"date":"2024-07-15","current":-5.156274,"twenty":-7.036695,"median":-4.107562,"eighty":-1.987953,"marketCap":151075105},{"date":"2024-08-02","current":-5.133561,"twenty":-6.901199,"median":-4.09548,"eighty":-1.949326,"marketCap":148625238},{"date":"2024-08-09","current":-7.140139,"twenty":-6.86257,"median":-4.09548,"eighty":-1.949326,"marketCap":167815860},{"date":"2024-08-16","current":-7.697465,"twenty":-6.911401,"median":-4.09548,"eighty":-1.949326,"marketCap":182146834},{"date":"2024-08-23","current":-7.236585,"twenty":-6.93312,"median":-4.09548,"eighty":-1.949326,"marketCap":173162013},{"date":"2024-08-30","current":-6.811696,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":162543588},{"date":"2024-09-06","current":-6.446567,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":153967167},{"date":"2024-09-13","current":-6.356329,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":151108360},{"date":"2024-09-20","current":-6.059129,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":145390747},{"date":"2024-09-27","current":-6.038208,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":145390747},{"date":"2024-10-04","current":-6.264984,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":148657954},{"date":"2024-10-11","current":-6.524269,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":153558766},{"date":"2024-10-18","current":-15.721494,"twenty":-7.01583,"median":-4.09548,"eighty":-1.949326,"marketCap":366744075},{"date":"2024-10-25","current":-12.110076,"twenty":-7.023279,"median":-4.09548,"eighty":-1.949326,"marketCap":281796672},{"date":"2024-10-31","current":-16.148416,"twenty":-7.060792,"median":-4.09548,"eighty":-1.949326,"marketCap":377725662},{"date":"2024-11-08","current":-14.267501,"twenty":-7.073439,"median":-4.092391,"eighty":-1.949322,"marketCap":368437326},{"date":"2024-11-15","current":-16.094368,"twenty":-7.098686,"median":-4.092391,"eighty":-1.949322,"marketCap":407654745},{"date":"2024-11-22","current":-14.835081,"twenty":-7.130789,"median":-4.092391,"eighty":-1.949322,"marketCap":372565476},{"date":"2024-11-29","current":-15.690865,"twenty":-7.14025,"median":-4.092391,"eighty":-1.949322,"marketCap":396302334},{"date":"2024-12-06","current":-14.437547,"twenty":-7.153344,"median":-4.092391,"eighty":-1.949322,"marketCap":365341214},{"date":"2024-12-13","current":-13.521478,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":339540281},{"date":"2024-12-20","current":-10.753984,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":267297668},{"date":"2024-12-27","current":-11.093016,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":276586004},{"date":"2025-01-03","current":-11.517358,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":282778228},{"date":"2025-01-10","current":-10.971159,"twenty":-7.153501,"median":-4.089301,"eighty":-1.949318,"marketCap":270393780},{"date":"2025-01-17","current":-9.63117,"twenty":-7.161996,"median":-4.089301,"eighty":-1.949318,"marketCap":237368585},{"date":"2025-01-24","current":-8.984838,"twenty":-7.177201,"median":-4.089301,"eighty":-1.949318,"marketCap":223952100},{"date":"2025-01-31","current":-8.890906,"twenty":-7.26829,"median":-4.089301,"eighty":-1.949318,"marketCap":221888025},{"date":"2025-02-07","current":-9.971289,"twenty":-7.296176,"median":-4.089301,"eighty":-1.949318,"marketCap":247688959},{"date":"2025-02-14","current":-9.369529,"twenty":-7.333672,"median":-4.089301,"eighty":-1.949318,"marketCap":234272473},{"date":"2025-02-21","current":-10.627937,"twenty":-7.333672,"median":-4.089301,"eighty":-1.949318,"marketCap":266265631},{"date":"2025-02-28","current":-9.693763,"twenty":-7.345472,"median":-4.089301,"eighty":-1.949318,"marketCap":241496735},{"date":"2025-03-07","current":-7.722265,"twenty":-7.421767,"median":-4.08841,"eighty":-1.949314,"marketCap":200215242},{"date":"2025-03-14","current":-5.953907,"twenty":-7.442244,"median":-4.08841,"eighty":-1.949314,"marketCap":179574495},{"date":"2025-03-21","current":-5.692868,"twenty":-7.442244,"median":-4.08841,"eighty":-1.949314,"marketCap":171496419},{"date":"2025-03-28","current":-5.020369,"twenty":-7.442244,"median":-4.08841,"eighty":-1.949314,"marketCap":150453913},{"date":"2025-04-04","current":-4.347953,"twenty":-7.442244,"median":-4.097034,"eighty":-1.949314,"marketCap":133619909},{"date":"2025-04-11","current":-3.828826,"twenty":-7.440844,"median":-4.09548,"eighty":-1.949318,"marketCap":118890155},{"date":"2025-04-17","current":-3.799201,"twenty":-7.440844,"median":-4.089301,"eighty":-1.949318,"marketCap":119942280},{"date":"2025-04-25","current":-5.139842,"twenty":-7.442244,"median":-4.08725,"eighty":-1.949314,"marketCap":162027291},{"date":"2025-05-02","current":-5.780364,"twenty":-7.442244,"median":-4.091173,"eighty":-1.949314,"marketCap":180965546},{"date":"2025-05-09","current":-4.791781,"twenty":-7.442244,"median":-4.101474,"eighty":-1.949314,"marketCap":163079416},{"date":"2025-05-16","current":-5.07944,"twenty":-7.442244,"median":-4.110156,"eighty":-1.949314,"marketCap":171496419},{"date":"2025-05-23","current":-5.227526,"twenty":-7.442244,"median":-4.110156,"eighty":-1.949314,"marketCap":178029607},{"date":"2025-05-30","current":-5.344536,"twenty":-7.442244,"median":-4.110156,"eighty":-1.949314,"marketCap":183296755},{"date":"2025-06-06","current":-5.455634,"twenty":-7.442244,"median":-4.130715,"eighty":-1.949314,"marketCap":188563903},{"date":"2025-06-13","current":-5.849843,"twenty":-7.442244,"median":-4.145599,"eighty":-1.949314,"marketCap":204365348},{"date":"2025-06-20","current":-5.904009,"twenty":-7.443643,"median":-4.131964,"eighty":-1.94931,"marketCap":204365348},{"date":"2025-06-27","current":-6.443873,"twenty":-7.443643,"median":-4.131964,"eighty":-1.94931,"marketCap":227540800},{"date":"2025-07-03","current":-6.468541,"twenty":-7.443643,"median":-4.131964,"eighty":-1.94931,"marketCap":229647659},{"date":"2025-07-11","current":-7.047118,"twenty":-7.443643,"median":-4.178422,"eighty":-1.94931,"marketCap":248609392},{"date":"2025-07-18","current":-7.227706,"twenty":-7.452141,"median":-4.206028,"eighty":-1.94931,"marketCap":252823111},{"date":"2025-07-25","current":-6.701186,"twenty":-7.452141,"median":-4.23371,"eighty":-1.94931,"marketCap":238075096},{"date":"2025-08-01","current":-6.407061,"twenty":-7.452141,"median":-4.242127,"eighty":-1.94931,"marketCap":221220222},{"date":"2025-08-08","current":-4.680407,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":215953074},{"date":"2025-08-15","current":-4.603915,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":212794985},{"date":"2025-08-22","current":-5.053389,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":232810354},{"date":"2025-08-29","current":-4.986722,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":230703473},{"date":"2025-09-05","current":-5.452284,"twenty":-7.453915,"median":-4.27508,"eighty":-1.949306,"marketCap":251772284},{"date":"2025-09-12","current":-4.951829,"twenty":-7.452141,"median":-4.285446,"eighty":-1.94931,"marketCap":230703473},{"date":"2025-09-19","current":-4.933801,"twenty":-7.452141,"median":-4.285446,"eighty":-1.94931,"marketCap":230703473},{"date":"2025-09-26","current":-4.70798,"twenty":-7.452141,"median":-4.296507,"eighty":-1.94931,"marketCap":218062187},{"date":"2025-10-03","current":-5.106615,"twenty":-7.452141,"median":-4.324369,"eighty":-1.94931,"marketCap":237024117},{"date":"2025-10-10","current":-5.741066,"twenty":-7.452141,"median":-4.363645,"eighty":-1.94931,"marketCap":263360130},{"date":"2025-10-17","current":-6.370512,"twenty":-7.452141,"median":-4.433688,"eighty":-1.94931,"marketCap":294963345},{"date":"2025-10-24","current":-6.451211,"twenty":-7.452141,"median":-4.469642,"eighty":-1.94931,"marketCap":297070226},{"date":"2025-10-31","current":-6.24628,"twenty":-7.452141,"median":-4.536885,"eighty":-1.94931,"marketCap":286535821},{"date":"2025-11-07","current":-4.74054,"twenty":-7.452141,"median":-4.61487,"eighty":-1.94931,"marketCap":232810354},{"date":"2025-11-14","current":-4.591644,"twenty":-7.452141,"median":-4.617864,"eighty":-1.94931,"marketCap":227545614},{"date":"2025-11-21","current":-4.417812,"twenty":-7.452141,"median":-4.622934,"eighty":-1.94931,"marketCap":217011095},{"date":"2025-11-28","current":-4.992811,"twenty":-7.452141,"median":-4.640927,"eighty":-1.94931,"marketCap":246507749},{"date":"2025-12-05","current":-4.498743,"twenty":-7.452141,"median":-4.664254,"eighty":-1.94931,"marketCap":223331807},{"date":"2025-12-12","current":-4.968906,"twenty":-7.452141,"median":-4.675134,"eighty":-1.94931,"marketCap":248614653},{"date":"2025-12-19","current":-4.425642,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":221224903},{"date":"2025-12-26","current":-4.558126,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":228599066},{"date":"2026-01-02","current":-4.256046,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":212797287},{"date":"2026-01-09","current":-4.459421,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":221224903},{"date":"2026-01-16","current":-3.368086,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":166445403},{"date":"2026-01-23","current":-3.60162,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":180140278},{"date":"2026-01-30","current":-3.318464,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":168552307},{"date":"2026-02-06","current":-3.064229,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":153803980},{"date":"2026-02-13","current":-2.898739,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":146429816},{"date":"2026-02-20","current":-3.091765,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":154857432},{"date":"2026-02-27","current":-3.33589,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":167498855},{"date":"2026-03-06","current":-3.616793,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":178033374},{"date":"2026-03-13","current":-3.726189,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":181193730},{"date":"2026-03-20","current":-3.443489,"twenty":-7.452141,"median":-4.664254,"eighty":-1.94931,"marketCap":167524091},{"date":"2026-03-27","current":-3.2482,"twenty":-7.429906,"median":-4.617864,"eighty":-1.94931,"marketCap":158041596}],"updateTime":1774719402074},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRQR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622904073","title":"ProQR Therapeutics to host virtual investor and analyst event; pipeline spotlight to include AX-0810 indication update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622904073","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622904073?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:04","pubTimestamp":1774440281,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics will host a virtual Investor and Analyst Event titled “Expanding the Axiomer RNA Editing Opportunity Beyond AX-0810” on April 8, 2026, from 10:00 a.m. ET to about 11:30 a.m. ET.The event will feature webcast presentations and a Q&A session with covering analysts and management.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDLmXYGS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4139","SG9999014021.USD","IE00BN0W2W23.USD","BK4588","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP","NDAQ","SG9999014005.SGD","LU2095319765.USD","BK4112","PRQR","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","SG9999014039.USD"],"gpt_icon":0},{"id":"2620262802","title":"ProQR Therapeutics’ Chief Scientific Officer Gerardus Johannes Platenburg files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262802","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262802?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:11","pubTimestamp":1773864714,"startTime":"0","endTime":"0","summary":"ProQR filed an initial statement of beneficial ownership for Gerardus Johannes Platenburg, a director and chief scientific officer. The filing reported 824,388 ordinary shares owned directly. It also listed share options covering 61,453 ordinary shares with an exercise price of USD 4.9. Another option covered 186,139 ordinary shares with an exercise price of USD 2.02.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3wLyN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2620878262","title":"ProQR Therapeutics NV Director Domenico Valerio Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620878262","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620878262?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:11","pubTimestamp":1773864683,"startTime":"0","endTime":"0","summary":"ProQR said director Domenico Valerio filed an initial statement of beneficial ownership. Valerio reported direct ownership of 420,729 ordinary shares. He also reported indirect ownership of 304,963 ordinary shares. Valerio reported share options covering 5,815 ordinary shares at an exercise price of USD 4.89. He also reported share options covering 32,164 ordinary shares at an exercise price of USD 4.9.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1ZCHvG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2620006264","title":"ProQR Therapeutics NV CFO Dennis Hom files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620006264","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620006264?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:09","pubTimestamp":1773864576,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics reported an initial statement of beneficial ownership for Dennis Hom, its chief financial officer. Dennis Hom reported share options to buy 750,000 ordinary shares at USD 1.66 per share. He also reported share options to buy 250,000 ordinary shares at USD 2.02 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL2NBFrs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2620264748","title":"ProQR Therapeutics director Alison Frances Lawton files Form 3 initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264748","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264748?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:08","pubTimestamp":1773864516,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics reported an initial statement of beneficial ownership for director Alison Frances Lawton. The filing listed share options to buy 5,815 ordinary shares at USD 4.89 per share. It also listed share options to buy 32,164 ordinary shares at USD 4.9 per share. Additional share options covered 25,192 ordinary shares at USD 2.02 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8mpFBk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2620715264","title":"ProQR Therapeutics NV Director Theresa Heggie files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620715264","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620715264?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:07","pubTimestamp":1773864423,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics reported an initial statement of beneficial ownership by director Theresa Heggie. Theresa Heggie reported direct beneficial ownership of 43,623 ordinary shares. She also reported share options covering 100,000 ordinary shares with an exercise price of USD 6.73. Additional share options reported include 80,594 ordinary shares at USD 0.67 and 78,556 ordinary shares at USD 1.02.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL2CXYld:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2620264220","title":"ProQR Therapeutics NV Director Bart Filius Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264220","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264220?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:06","pubTimestamp":1773864370,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics reported an initial statement of beneficial ownership by director Bart Filius. The filing disclosed share options to buy 12,755 ordinary shares at USD 11.69 per share. It also reported share options for 24,615 ordinary shares at USD 9.91 per share. Additional share options covered 23,239 ordinary shares at USD 4.2 per share. The filing also listed share options for 25,192 ordinary shares at USD 2.02 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9syNjx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2620264400","title":"ProQR Therapeutics NV CEO and Director Daniel Anton de Boer files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264400","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264400?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:04","pubTimestamp":1773864261,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics reported an initial statement of beneficial ownership for Daniel Anton de Boer, its chief executive officer and a director. The filing listed share options covering 1.2 million ordinary shares with an exercise price of USD 0.66. It also listed share options covering 1.4 million ordinary shares with an exercise price of USD 2.16.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLg8XWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2620642882","title":"ProQR Therapeutics NV Director Begona Carreno-Gomez Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620642882","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620642882?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:04","pubTimestamp":1773864250,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics reported an initial statement of beneficial ownership for director Begona Carreno-Gomez. The filing listed share options covering 3,565 ordinary shares with an exercise price of USD 0.95. It also reported share options covering 25,192 ordinary shares with an exercise price of USD 2.02.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL130Yvc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2620264493","title":"ProQR Therapeutics NV files Form 3 initial beneficial ownership statement for Director Shannon James Samuel","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264493","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264493?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:02","pubTimestamp":1773864147,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics reported that director Shannon James Samuel filed an initial statement of beneficial ownership. Samuel reported direct ownership of 61,538 ordinary shares. Samuel also reported share options covering 33,069 ordinary shares with an exercise price of USD 4.89. He also reported share options covering 32,164 ordinary shares with an exercise price of USD 4.9.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL95mvr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2619714689","title":"ProQR Therapeutics Q4 Net Loss Of €8.9 Million Reinforces Profitability Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2619714689","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619714689?lang=en_us&edition=fundamental","pubTime":"2026-03-14 06:31","pubTimestamp":1773441090,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics (NasdaqCM:PRQR) has wrapped up FY 2025 with fourth quarter revenue of €4.7 million and a basic EPS loss of €0.08, alongside a net income loss of €8.9 million. These figures put hard numbers around where the business stands today. Over recent periods the company has seen quarterly revenue range from €2.9 million to €4.7 million, while quarterly basic EPS has moved between a loss of €0.12 and a loss of €0.08. As a result, the story for investors remains centered on how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prqr/proqr-therapeutics/news/proqr-therapeutics-q4-net-loss-of-89-million-reinforces-prof","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prqr/proqr-therapeutics/news/proqr-therapeutics-q4-net-loss-of-89-million-reinforces-prof","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","BK4007","BK4139","LENZ","PRQR"],"gpt_icon":0},{"id":"2619630051","title":"ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2619630051","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619630051?lang=en_us&edition=fundamental","pubTime":"2026-03-13 14:01","pubTimestamp":1773381660,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics BV (PRQR) has disclosed a new risk, in the Share Price & Shareholder Rights category. ProQR Therapeutics BV faces heightened ris...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/proqr-therapeutics-faces-heightened-activist-investor-pressure-and-governance-uncertainty?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/proqr-therapeutics-faces-heightened-activist-investor-pressure-and-governance-uncertainty?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRQR","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2618513276","title":"ProQR Therapeutics NV reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2618513276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618513276?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:18","pubTimestamp":1773321515,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV reports results for the quarter ended December 31 - Earnings SummaryProQR Therapeutics NV PRQR.OQ reported a quarterly adjusted loss of 8 cents per share for the quarter ended De","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL8N4001M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2618136620","title":"ProQR FY 2025 net loss rises 52% to EUR 42.2 million as cash falls 38% to EUR 92.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618136620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618136620?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:05","pubTimestamp":1773313534,"startTime":"0","endTime":"0","summary":"ProQR reported a FY 2025 net loss of EUR 42.2 million, or EUR 0.4 per diluted share. Cash and cash equivalents were EUR 92.4 million at year-end 2025, down 38% from the prior year-end. FY 2025 R&D costs rose 23% to EUR 44.7 million, while G&A costs increased 10% to EUR 15.1 million. Net cash used in operating activities was EUR 52.8 million, up 45%, and the company said it achieved USD 4.5 million in Eli Lilly collaboration milestones during FY 2025. Management said the cash position supports runway into mid-2027 and expects AX-0810 Phase 1 target engagement data in 1H 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL72WVd5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","IE00B64PRP62.GBP","LU2168564149.EUR","LU1145028129.USD","IE00B3QW5Z07.USD","LU0471298777.SGD","LU0823434583.USD","LU0964807845.USD","LU1868837136.USD","SG9999014005.SGD","IE0002141913.USD","LU2896262040.SGD","IE00BK4W5L77.USD","LU0466842654.USD","IE00B4JS1V06.HKD","LU0256863811.USD","LU2756315664.SGD","SGXZ99366536.SGD","LU1988902786.USD","LU0417517546.SGD","LU2324357040.USD","LU2552382215.SGD","SG9999014914.USD","LU2471134879.HKD","LU1323610961.USD","LU2168564222.USD","IE0005OL40V9.USD","LU2168563687.JPY","IE00BJJMRZ35.SGD","LU1868837300.USD","LU1983299246.USD","LU0683600562.USD","LU2491049909.HKD","SG9999001176.SGD","LU1093756168.USD","LU0203201768.USD","LU0823416689.USD","LU2237438978.USD","LU2756315318.SGD","SG9999014013.SGD","LU1720051017.SGD","LU1035775433.USD","LU2112291526.USD","LU1868836914.USD","LU0234572021.USD","LU2211815571.USD","LU2456880835.USD","LU1917777945.USD","LU0109394709.USD","LU2602419157.SGD","LU0471298694.HKD","LU1093756325.SGD","SG9999017495.SGD","LU2491050154.USD","LU0385154629.USD","LU0094547139.USD","BK4581","LU0820561818.USD","LU2089283258.USD","LU0820561909.HKD","LU2210150020.SGD","LU0353189763.USD","LU0114720955.EUR","LU0122379950.USD","LU2271345857.HKD","BK4534","LU0097036916.USD","LU0266013472.USD","LU1061106388.HKD","LU2168564065.EUR","LU2471134952.CNY","IE00BWXC8680.SGD","PRQR","IE00BGHQF748.EUR","BK4533","LU0061475181.USD","LU0316494557.USD","LU0210536198.USD","LU0106261372.USD","LU0314104364.USD","LU2361044949.HKD","IE00B1XK9C88.USD","LU0889565916.HKD","SGXZ31699556.SGD","LU1868836757.USD","LU2750360997.AUD","LU0238689110.USD","LU2491050071.SGD","SG9999015945.SGD","LU2089284900.SGD","LU2237443465.HKD","LU0354030438.USD","LU0320765059.SGD","LU2471134796.USD","LU2236285917.USD","LU0787776722.HKD","BK4516","LU0320765992.SGD","LU2168564495.EUR","BK4139","LU1232071149.USD","LU2237443382.USD","LU1804176565.USD","IE00B4R5TH58.HKD","LU2095319765.USD","LU2417539215.USD","LU2264538146.SGD","LU0820562030.AUD","IE00BJJMRY28.SGD","LU2361044865.SGD","LU0882574055.USD","LLYX","IE00B2B36J28.USD","LU0203202063.USD","LU2089984988.USD","BK4112","LU1814569148.SGD","SG9999014021.USD","LU0256863902.USD","LU2087625088.SGD","LU0353189680.USD","IE0004445239.USD","LU0689472784.USD","LU1023059063.AUD","SG9999014039.USD","SG9999014898.SGD","LU1989771016.USD","LU1551013342.USD","LU2028103732.USD","IE00B7KXQ091.USD","IE0001KFT4U8.USD","LU1974910355.USD","LU2361045086.USD","LU1548497426.USD","IE00BKDWB100.SGD","LLII","LU2023251221.USD","LU0323591593.USD","BK4007","IE00BJT1NW94.SGD","IE00BN29S564.USD","LU0158827948.USD","LU1366192091.USD","LU1623119135.USD","LU2552382132.HKD","LU2063271972.USD","LU1712237335.SGD","BK4585","LU2108987350.USD","LU0225283273.USD","LU0198837287.USD","LLYZ","IE00BFSS7M15.SGD","LU0432979614.USD","LU2213496289.HKD","LU1551013425.SGD","IE00B775H168.HKD","LU2746668974.SGD","ELIL","SG9999001176.USD","LU1280957306.USD","LU0882574139.USD","LU2357305700.SGD","LU2552382058.USD","LU2746668461.USD","LU1868836591.USD","LU0058720904.USD","LU0079474960.USD","ELIS","LU0158827781.USD","LU2237443895.HKD","LU2468319806.SGD","SGXZ57979304.SGD","LU0708995401.HKD","SG9999014880.SGD","LU1720051108.HKD","LU0943347566.SGD","LU0786609619.USD","LU1127390331.HKD","LU1629891620.HKD","SG9999015978.USD","BK4588","LU0823434740.USD","LU2237443978.SGD","GB00BDT5M118.USD","LU2023250504.SGD","LU2360106947.USD","LU2461242641.AUD","SG9999018865.SGD","LU2210149790.SGD","LU1069344957.HKD","LU2237443622.USD","SG9999015986.USD","LU0006306889.USD","LU2462157665.USD","IE0009355771.USD","BK4599","LU2111349929.HKD","LU2106854487.HKD","LU0640476718.USD","LU1064131342.USD","SG9999014906.USD","IE00BFSS8Q28.SGD","SG9999015952.SGD","IE0004445015.USD","LU1267930730.SGD","LU1291159041.SGD","IE00BKPKM429.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","LU0672654240.SGD","LU2471134523.USD","SGXZ81514606.USD","LU2750360641.GBP","IE00BK4W5M84.HKD","LU2023250330.USD","IE00BJJMRX11.SGD","SG9999018857.SGD","LU0456855351.SGD","SGXZ51526630.SGD","LU0096364046.USD","LU0289739699.SGD","LU1057294990.SGD","LU2237443549.SGD","SG9999013999.USD","IE00BJLML261.HKD","LU2265009873.SGD","LU0354030511.USD"],"gpt_icon":0},{"id":"2618135014","title":"ProQR Announces Year End 2025 Operating and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2618135014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618135014?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:00","pubTimestamp":1773313204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUA95JY8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2618254926","title":"ProQR Therapeutics NV  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2618254926","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618254926?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:18","pubTimestamp":1773058720,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV  expected to post a loss of10cents a share - Earnings Preview ProQR Therapeutics NV PRQR.OQ PRQR.O is expected to  show a fall in quarterly revenue when it reports  results on Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL8N3ZX11O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2616837203","title":"ProQR Therapeutics to Present at Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2616837203","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616837203?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:03","pubTimestamp":1772575385,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics to Present at Citizens Life Sciences Conference               ProQR Therapeutics N.V. management will present at the Citizens Life Sciences Conference on March 11, 2026 at 3:25 p.m.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDLc7YmR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","PRQR","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","BK4139","BK4588","NDAQ","SG9999014005.SGD","LU0314104364.USD","SG9999014039.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2610658235","title":"ProQR Therapeutics kündigt Wechsel im Vorstand an","url":"https://stock-news.laohu8.com/highlight/detail?id=2610658235","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610658235?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642025,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via GlobeNewswire  on February 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL8wQd47:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4588","BK4112","NDAQ","PRQR","IE00B3QW5Z07.USD","BK4139","SG9999014005.SGD","SG9999014021.USD","BK4585","IE00BGHQF748.EUR","SG9999014013.SGD","LU0314104364.USD","LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD"],"gpt_icon":0},{"id":"2601936270","title":"BRIEF-Proqr Announces Encouraging Ax-0810 Phase 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2601936270","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601936270?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:39","pubTimestamp":1767879544,"startTime":"0","endTime":"0","summary":"BRIEF-Proqr Announces Encouraging Ax-0810 Phase 1 Jan 8 (Reuters) - ProQR Therapeutics NV PRQR.O:PROQR ANNOUNCES ENCOURAGING AX-0810 PHASE 1 SAFETY AND PK DATA, DEVELOPMENT CANDIDATE SELECTIONS, AND 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4HNXKC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2601364343","title":"ProQR Reports Positive Initial Safety Data from AX-0810 Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364343","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364343?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:01","pubTimestamp":1767877269,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV announced encouraging initial safety and pharmacokinetic  data from the first cohort of healthy volunteers in its ongoing Phase 1 trial of AX-0810. The initial results, which showed no safety signals after four weeks of dosing and PK consistent with non-clinical data, support continued dosing in the study. Enrollment and dosing of healthy volunteers are ongoing, with target engagement data expected in the first half of 2026. Additionally, ProQR reported new non-clinical functional proof-of-concept data for AX-2911, which demonstrated over 80% reduction in hepatic fat content in a humanized PNPLA3-148M mouse model, outperforming a clinical-stage PNPLA3-directed antisense therapy. Further details and analyses on AX-2911 will be presented at a later date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL3LYXJt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","PRQR","NDAQ","SG9999014021.USD","IE00BKPKM429.USD","BK4585","IE00BGHQF748.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","LU2210150020.SGD","LU2095319765.USD","BK4139","SG9999014039.USD","SG9999014005.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}]}}